Can-Fite Biopharma LTD. (CANF) SEC Filings — 2025
30 SEC filings for Can-Fite Biopharma LTD. (CANF) in 2025.
Filings
- Can-Fite BioPharma Files 6-K, Incorporates Press Release — 6-K · Dec 29, 2025
- Can-Fite Biopharma LTD. 6-K Filing — 6-K · Dec 23, 2025
- Can-Fite BioPharma Files 6-K, Incorporates Press Release — 6-K · Dec 16, 2025
- Can-Fite Biopharma LTD. 6-K Filing — 6-K · Nov 21, 2025
- Can-Fite BioPharma Files 6-K Report — 6-K · Nov 20, 2025
- Can-Fite Biopharma LTD. 6-K Filing — 6-K · Nov 18, 2025
- Can-Fite Biopharma LTD. 6-K Filing — 6-K · Nov 10, 2025
- Can-Fite Biopharma LTD. 6-K Filing — 6-K · Nov 3, 2025
- Can-Fite BioPharma to Restructure into New Entity '03 Life Sciences' — 6-K · Oct 3, 2025
- Can-Fite BioPharma Files 6-K, Updates SEC Filings — 6-K · Sep 15, 2025
- Can-Fite BioPharma Ltd. Files 6-K for June 30, 2025 — 6-K · Aug 28, 2025
- Can-Fite BioPharma Pancreatic Cancer Study Hits Enrollment Milestone — 6-K · Jul 30, 2025
- Can-Fite BioPharma's Piclidenoson Shows Promise in HS Study — 6-K · Jul 29, 2025
- Can-Fite's Piclidenoson Shows Promise for Vascular Dementia — 6-K · Jul 28, 2025
- Can-Fite BioPharma Shareholders Approve All Six Proposals — 6-K · Jun 30, 2025
- Can-Fite BioPharma Annual Meeting Adjourned Due to Lack of Quorum — 6-K · Jun 23, 2025
- Can-Fite BioPharma to Present Pancreatic Cancer Study Update at BIO Convention — 6-K · Jun 16, 2025
- Can-Fite BioPharma Files Form 6-K — 6-K · May 16, 2025
- Can-Fite BioPharma Raises $175M for Liver Cancer & Psoriasis Drugs — 6-K · May 5, 2025
- Can-Fite BioPharma Files 6-K, Incorporates Press Release — 6-K · Apr 17, 2025
- Can-Fite BioPharma Files 6-K, Incorporates Previous Filings — 6-K · Apr 15, 2025
- Can-Fite BioPharma Files 2024 Annual Report — 20-F · Apr 14, 2025
- Can-Fite BioPharma Establishes New Subsidiary for Drug Development — 6-K · Mar 24, 2025
- Can-Fite BioPharma Files 6-K Report — 6-K · Mar 20, 2025
- Can-Fite BioPharma Ltd. Incorporates Israeli Subsidiary — 6-K · Mar 19, 2025
- Can-Fite BioPharma Files Routine 6-K Report — 6-K · Mar 18, 2025
- Can-Fite BioPharma Publishes Namodenoson Liver Cancer Research — 6-K · Mar 3, 2025
- Can-Fite BioPharma Files 6-K, Incorporates Press Release — 6-K · Feb 18, 2025
- Can-Fite BioPharma to Present Namodenoson Obesity Data — 6-K · Feb 5, 2025
- Can-Fite BioPharma Secures US Patent for Obesity Drug Namodenoson — 6-K · Jan 27, 2025